Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New PKB inhibitors presented by GlaxoSmithKline

Sep. 2, 2010

Bayer Schering Pharma identifies new Akt inhibitors

Sep. 2, 2010

Celgene discovers new isotopologues of lenalidomide

Sep. 1, 2010

Phase II and III trials examine SIR-Spheres in patients with refractory colorectal liver metastases

Sep. 1, 2010

Yissum claims new MMP-2 inhibitors

Sep. 1, 2010

Patient recruitment begins for phase II MK-2206 trial in colorectal cancer

Aug. 31, 2010

FDA extends review of eribulin NDA for advanced or metastatic breast cancer

Aug. 31, 2010

Genentech describes selection of novel Chk1 inhibitor for further development

Aug. 31, 2010

Tasigna approved in Switzerland for Ph+ chronic myeloid leukemia

Aug. 30, 2010

SuperGen discovers new inhibitors of tyrosine-protein kinase receptor UFO

Aug. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...